T Cell Therapy of Opportunistic Cytomegalovirus Infection

Clinical trial NCT02982902 · RECRUITING

Trial details

NCT number: NCT02982902
Sponsor: Mari Dallas
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cytomegalovirus Infections Hematopoietic Stem Cell Transplant Opportunistic Infections

Start date: 2020-05-27
Primary completion: 2027-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.